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Moraxella catarrhalis is one of the major pathogens
of respiratory and middle ear infections.  β-Lactamase
production is the principal mechanism of antibiotic
resistance in this bacterium and in several countries
100% of the M. catarrhalis is a β-lactamase producer
(10).  Although the bacterium does not produce any
enzymes that compromise the host mucosal defenses,
the attachment of M. catarrhalis to host cells plays an
important role in the pathogenesis of infections.  Thus
therapeutic use of anti-attachment molecules for M.
catarrhalis infections may be an option that needs
proper evaluation before considering using in vivo.  To
human respiratory cells M. catarrhalis carries two dif-
ferent binding specificities, one in the recognition of
GalNAcβ1-4(NeuAcα2-3) present in different ganglio-
sides, and the other is asialoganglioside GM1 (1, 2).  It
is not uncommon for bacteria to use multiple receptors
on the host cells for firm attachment (8).  Since sul-
fatides are found in the extracellular matrix, in mucus
and on the surface of epithelial cells of human trachea
and lungs (6), there is a possibility that M. catarrhalis
might use them as an attachment molecule.  Therefore
this study was done to define the role of sulfatide as a
molecule for attachment of M. catarrhalis to human air-
way epithelial cells and to evaluate the potential of its
synthetic analogues as an anti-attachment agent.
M. catarrhalis strain B-88-152 was used in this
study.  Only in thin layer chromatography (TLC) an
additional four strains of M. catarrhalis, B-87-69, B-
87-75, B-87-94 and B-87-133 were used.  All strains
were isolated from the sputum of patients with respira-
tory infections and the culture conditions are described
elsewhere (1).
The glycoconjugates used in this study were a natural
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Abstract: Moraxella catarrhalis is one of the major pathogens of respiratory and middle ear infections.
Attachment of this bacterium to the surface of human pharyngeal epithelial cells is the first step in the
pathogenesis of infections. This study revealed that sulfatide might act as a binding molecule for the
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fatides were found to inhibit the attachment of M. catarrhalis significantly at an optimum concentration of
10 g/ml. Synthetic sulfatides may have the potential to be used as a therapy to prevent M. catarrhalis
infections.
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sulfated gangliosides mixture, sulfatides (3-SO3-Gal-
Cer), galactosylceramide (GalCer) and synthetic sul-
fatides.  The sulfated gangliosides mixture (GM1a,
GD1a, GD1b and GT1b) was prepared from ganglio-
sides purified from bovine brains (7).  The structures of
the per-O-sulfated gangliosides were supported by the
positive ion fast bombardment mass spectrometry
(JMS-SX102, JEOL, Tokyo).  Sulfatide was isolated
from fresh bovine brain by procedures as described
elsewhere (14).  Galactosylceramide was a desulfated
form of sulfatide.
In this study, the following synthetic sulfatide ana-
logues were also used: polymeric poly-(3-SO3-Gal)
[sugar:AA (polyacrylamide)36:64], poly-(6-SO3-
Gal) [sugar:AA6:94] and poly-(3,6-SO3-Gal) [sugar:
AA6:94], and monomeric 6-SO3-Gal-pNP (p-nitro-
phenyl) and 3,6-SO3-Gal-pNP.  They were prepared
according to the methods described previously (9,
15–17).  Na2SO3 (sodium sulfite) was purchased from
Sigma (Sigma Chemical Co., St. Louis, Mo., U.S.A.).
A mouse anti-sulfatide mAb, GS-5 (IgM), was pre-
pared as described previously (13).  The culture super-
natant from hybridoma cells was obtained and stored at
80 C until used.  The GS-5 mAb was found to recog-
nize sulfatide and seminolipid (HO3S-3Galβ1-alkyl-
acylglycerol) and not other related sulfated gly-





4Glcβ1-1' ceramide] (13). 
An attachment inhibition assay was done with two
different established approaches (1, 2): one was to
determine the effect of different glycoconjugates sus-
pended in 1/15 mol phosphate buffer, pH 7.2, and the
other was to determine the effect of anti-sulfatide anti-
body on human pharyngeal epithelial cells (HPECs).
The mean of the duplicate experiment was determined
in each experiment.  At least three experiments were
done for each potential inhibitor and its control.  Stu-
dent’s t test was done to find the significance; a P value
of 0.05 was considered significant.  After the treat-
ment with glycoconjugates at a concentration of 100
µg/ml the viability of M. catarrhalis was determined by
quantitative culture (1).  TLC was performed with sul-
fatide and GalCer dissolved in methanol according to
the methods described previously (2). 
Compared to the control there was a significant dose
dependent inhibition of attachment of M. catarrhalis
(28.911.4, 37.416.8 and 43.914.4% of the con-
trol) when the bacteria were treated with 100, 10, 1
µg/ml of sulfatide (Fig. 1).  However no significant
effects were observed at a dose of 0.1 µg/ml
(101.77.9% of control).  Again compared to the con-
trol there was a significant decrease of attachment
(17.57.2, 16.59.6 and 19.76.3% of the control)
when M. catarrhalis was treated with 100, 10 and 1
µg/ml of sulfated gangliosides (Fig. 1).  However there
was no significant decrease of attachment (58.519.4,
87.938.0 and 94.238.7% of the control) when M.
catarrhalis was treated with 0.1, 0.01 and 0.001 µg/ml
of sulfated gangliosides.  A dose dependent effect was
seen in this attachment inhibition assay.  Compared to
the control there was no significant difference when M.
catarrhalis was treated with 100 and 10 µg/ml of
Na2SO3 (100.622.6 and 96.043.5% of the control)
and GalCer (95.78.1 and 77.619.6% of the control).
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Fig. 1. Results of attachment inhibition assay using strain B-88-152 are shown in two different panels. The left and
right panels are for sulfatide and sulfated ganglioside mixture, respectively. The concentrations of glycoconjugates in
µg/ml are shown in the X axis. Y axis indicates the attachment of bacteria per epithelial cell expressed as percentage of
the respective control. P values of 0.01, 0.005 and 0.001 are indicated by **, *** and ****, respectively.
Figure 2 shows the effects of different synthetic sul-
fatides at concentrations of 100, 10 and 1 µg/ml, on the
attachment inhibition of M. catarrhalis.  There was a
significant decrease of attachment except for pNP 6-
SO3-Gal, pNP 3,6-SO3-Gal and poly-(3-SO3-Gal) at
concentrations of 1, 1 and 100 µg/ml, respectively.  At a
concentration of 100 µg/ml pNP 6-SO3-Gal showed a
borderline significant (P0.06) decrease of attachment.
Compared to the untreated control, there was no differ-
ence of viability after bacteria were treated with differ-
ent glycoconjugates.
When HPECs were treated with 1:100 and 1:1,000
dilution of mAb, the attachment of M. catarrhalis was
23.14.1 and 66.743.5% of the control, respectively.
Statistical significance (P0.0005) was obtained at
1:100 dilution only.  For all strains, a dark band
becomes visible on the TLC plate signifying a strong
positive interaction of M. catarrhalis with sulfatide,
while for GalCer the interaction varied from weak to
strong for different strains at separate experiments.  
A key virulence element of M. catarrhalis is its abili-
ty to bind with the molecules present on host cells.
This study provided evidence that sulfatide can act as a
molecule for the attachment of M. catarrhalis to
HPECs.  No significant inhibition was observed when
bacteria were treated with sodium sulfite indicating the
interaction of sulfatide is specific and not an ionic inter-
action.  Utilizing different types of binding molecules is
not uncommon in microorganisms; many bacteria such
as Bordetella pertussis (4) attach with sulfatide as well
as with asialo GM1.  The parallel occurrence of sialic
acid and sulfate group specificities has been observed
with other lectins also (11).  This shows the use of mul-
tiple receptors might reflect a specialized adaptation of
M. catarrhalis to the human respiratory tract.  It pro-
vides an advantage to this bacterium to bind strongly
with the cell surface to overcome the normal cleansing
mechanism in respiratory organs. 
Sulfated derivatives of polysaccharides have been
reported to have much stronger activities than non-sul-
fated polysaccharides (7); therefore sulfated ganglio-
sides were examined in this study to find out their
effects on the attachment inhibition of M. catarrhalis.
Sulfated gangliosides showed a remarkable decrease of
attachment possibly due to their possession of sialic
acid as well as sulfatide part.  A past report indicated
that sialic acid is important for the attachment of M.
catarrhalis to HPECs (1). 
In the present study M. catarrhalis showed interac-
tion, although occasionally weak, with GalCer on TLC
plate.  This disparity from our earlier report (2) is due to
different culture conditions used in these two experi-
ments.  Most importantly in attachment inhibition
assays, GalCer could not inhibit the attachment of M.
catarrhalis to HPECs.  TLC enabled detection of low-
affinity cooperative multi-site interactions that would
escape detection by soluble univalent receptors in
attachment inhibition experiments (12).  Therefore
interaction of M. catarrhalis with GalCer on the cell
surface is probably of too low avidity to be important
for pathogenesis.  Sulfatide mediated attachment may
ultimately guarantee the bacteria for intimate contact
necessary for pathogenesis as its interaction occurring
both polyvalent and monovalent presentation. 
969NOTES
Fig. 2. Results of attachment inhibition assay using strain B-88-152 are shown in two different panels. The left panel
is for monomeric glycoconjugates, 6-SO3-Gal-pNP (p-nitrophenyl) and 3,6-SO3-Gal-pNP are indicated by open and
closed column, respectively. The right panel is for polymeric glycoconjugates, poly-(3-SO3-Gal) [sugar:AA (poly-
acrylamide)36:64], poly-(6-SO3-Gal) [sugar:AA6:94], poly-(3,6-SO3-Gal) [sugar:AA6:94] are indicated by
open, closed and hatched column, respectively. The concentrations of glycoconjugates in µg/ml are shown in the X
axis. Y axis indicates the attachment of bacteria per epithelial cell expressed as percentage of the respective control. P




The interaction of M. catarrhalis with different syn-
thetic glycoconjugates was variable.  For example even
at a lower concentration, polymeric glycoconjugates
showed stronger inhibition of bacterial attachment.
This is because increasing carbohydrate ligand concen-
tration does not always lead to an increase in binding
with the complementary protein (3).  There is also a
possibility that the interaction of synthetic glycoconju-
gate with respective adhesin leads to some conforma-
tional changes (5) of other adhesin molecules of M.
catarrhalis thus caused variable results.  Among the
synthetic glycoconjugates tested in this study, pNP 3,6-
SO3-Gal seems to be a promising candidate since it
showed dose dependent attachment inhibition.  Other-
wise all the synthetic glycoconjugates showed a signifi-
cant decrease of attachment at 10 µg/ml; therefore this
concentration is optimal to inhibit the attachment of M.
catarrhalis to HPECs.  In the present study cells were
directly obtained from the human pharynx which
reflects the behavior of pathogen-host interaction faith-
fully.  We hope that these results will help in the future
to conduct in vivo studies to find out the effects of these
synthetic glycoconjugates in the prevention of M.
catarrhalis infection.
Part of this project was supported by the Bilkent University
Research Development Grant Program (2003-2004 to K.A.) and
the Japan Health Science Foundation (to Y.S.). 
References
1) Ahmed, K., Matsumoto, K., Rikitomi, N., and Nagatake, T.
1996. Attachment of Moraxella catarrhalis to pharyngeal
epithelial cells is mediated by a glycosphingolipid receptor.
FEMS Microbiol. Lett. 135: 305–309.
2) Ahmed, K., Suzuki, Y., Miyamoto, D., and Nagatake, T.
2002. Asialo-GM1 and asialo-GM2 are putative adhesion
molecules for Moraxella catarrhalis. Med. Microbiol.
Immunol. 191: 5–10.
3) Bovin, N.V. 1998. Polyacrylamide-based glycoconjugates
as tools in glycobiology. Glycoconjugate J. 15: 431–446.
4) Brennan, M.J., Hannah, J.H., and Leininger, E. 1991.
Adhesion of Bordetella pertussis to sulfatides and to the
GalNAcβ4Gal sequence in glycosphingolipids. J. Biol.
Chem. 266: 18827–18831.
5) Dimitrov, D.S. 2004. Virus entry: molecular mechanisms
and biomedical applications. Nat. Rev. Microbiol. 2:
109–122.
6) Geuijen, C.A., Willems, R.J., and Mooi, F.R. 1996. The
major fimbrial subunits of Bordetella pertussis binds to sul-
fated sugars. Infect. Immun. 64: 2657–2665.
7) Handa, A., Hoshino, H., Nakajima, K., Adachi, M., Ikeda,
K., Achiwa, K., Itoh, T., and Suzuki, Y. 1991. Inhibition of
infection with human immunodeficiency virus type 1 by
sulfated gangliosides. Biochem. Biophys. Res. Commun.
175: 1–9. 
8) Hasty, D.L., Ofek, I., Courtney, H.S., and Doyle, R.J. 1992.
Multiple adhesions of Streptococci. Infect. Immun. 60:
2147–2152.
9) Nishida, Y., Uzawa, H., Toba, T., Sasaki, K., Kondo, H.,
and Kobayashi, K. 2000. A facile synthetic approach to L-
and P-selectin blockers via copolymerization of vinyl
monomers constructing the key carbohydrate modules of
sialyl LewisX mimics. Biomacromolecules 1: 68–74. 
10) Ozyilmaz, E., Akan, O.A., Gulhan, M., Ahmed, K., and
Nagatake, T. 2005. Major bacteria of community acquired
respiratory tract infections in Turkey. Jpn. J. Infect. Dis. 58:
50–52.
11) Simon, P.M., Goode, P.L., Mobasseri, A., and Zopf, D.
1997. Inhibition of Helicobacter pylori binding to gastroin-
testinal epithelial cells by sialic acid-containing oligosac-
charides. Infect. Immun. 65: 750–757.
12) Stromberg, N. 1990. Carbohydrates as recognition mole-
cules for bacterial adhesins: methodology and characteris-
tics. Arch. Oral Biol. 35 [Suppl]: 131S–135S.
13) Suzuki, Y., Nishi, H., Hidari, K., Hirabayashi, Y., Matsu-
moto, M., Kobayashi, T., Watari, S., Yasuda, T., Nakayama,
J., Maeda, H., Katsuyama, T., Kanai, M., Kiso, M., and
Hasegawa, A. 1991. A new monoclonal antibody directed to
sialyl α2-3 lactoneotetraosylceramide and its application
for detection of human gastrointestinal neoplasmas. J.
Biochem. 109: 354–360.
14) Suzuki, Y., Toda, Y., Tamatani, T., Watanabe, T., Suzuki,
T., Nakao, T., Murase, K., Kiso, M., Hasegawa, A.,
Tadano-Aritomi, K., Ishizuka, I., and Miyasaka, M. 1993.
Sulfated glycolipids are ligands for lymphocyte homing
receptor, L-selectin (LECAM-1), binding epitope in sulfated
sugar chain. Biochem. Biophys. Res. Commun. 190:
426–434.
15) Uzawa, H., Nishida, Y., Sasaki, K., Minoura, N., and
Kobayashi, K. 2003. Synthetic potential of molluscan sulfa-
tases for the library synthesis of regioselectively O-sul-
fonated D-galacto-sugars. ChemBioChem 4: 640–647. 
16) Uzawa, H., Nishida, Y., Sasaki, K., Nagatsuka, T., Hirama-
tsu, H., and Kobayashi, K. 2004. Sulfatase-catalyzed
assembly of regioselectively O-sulfonated p-nitrophenyl α-
D-gluco- and α-D-mannopyranosides. Carbohydr. Res. 339:
1597–1602.
17) Uzawa, H., Toba, T., Nishida, Y.,  Kobayashi, K., Minoura,
N., and Hiratani, K. 1998. Convenient synthetic approach
towards regioselectively sulfated sugars using limpet and
abalone sulfatase-catalyzed desulfation. Chem. Commun.
1998: 2311–2312.
970 P. OZCELIK ET AL
